Claim

Lockheed Martin Faces Class Action Lawsuit as Investors Claim Misleading Financial Practices Led to Billions in Losses

by

SAN FRANCISCO — A securities class action lawsuit has been initiated against Lockheed Martin Corporation in response to allegations that the aerospace giant misled investors regarding its financial status. The suit, identified as Khan v. Lockheed Martin Corporation, claims the company failed to reveal insufficient internal controls to evaluate program risks, affecting investor decisions. This lawsuit pertains to shareholders who purchased stock between January 23, 2024, and July 21, 2025. According to the filing, Lockheed Martin’s representations during this period painted an inaccurately optimistic view of its operational health, particularly regarding its Aeronautics and Rotary … Read more

IMAX CEO’s Partying Lifestyle Sparks Legal Battle Over Ex-Wife’s Insurance Policy Claim

by

Richard Gelfond, the CEO of IMAX and a prominent figure in the film industry, is facing significant challenges related to his personal life, particularly regarding a life insurance policy. Gelfond’s ex-wife, Linda Stein, has claimed that his lifestyle choices, including allegations of drug and alcohol abuse, have led multiple insurance companies to deny her requests for a $4.5 million policy on his life. Stein, aged 70, filed sealed court documents last week in Manhattan, stating that two insurance companies have refused her applications based on Gelfond’s reported use of cocaine and excessive drinking. Gelfond, who … Read more

Capricor Therapeutics Faces Class Action Lawsuit as Investors Claim Misleading Statements Led to Financial Losses

by

Los Angeles, Calif. — A class action lawsuit has been initiated against Capricor Therapeutics, Inc. (CAPR) in response to claims that the company’s stock was sold at inflated prices. Filed by the law firm Levi & Korsinsky on July 17, 2025, the lawsuit alleges that shareholders purchased stock during a defined class period from October 9, 2024, to July 10, 2025, without full knowledge of the company’s actual financial condition. Affected investors are being encouraged to seek information on participation in the action. Capricor Therapeutics is engaged in the development of innovative cell and exosome-based … Read more

Johnson & Johnson Faces Legal Setback as Bankruptcy Court Challenges Talc Claim Settlements

by

GREENWOOD VILLAGE, Colo. — Johnson & Johnson faced a significant setback in its legal battles as a federal bankruptcy court ruled against one of its recent maneuvers to address claims related to its talc-based products. This decision underscores growing scrutiny of corporate strategies designed to limit liability as the company contends with numerous lawsuits alleging that its talcum powder contains cancer-causing asbestos. The ruling represents a crucial chapter in Johnson & Johnson’s ongoing fight against approximately 38,000 lawsuits tied to its talc products, most notably Johnson’s Baby Powder. Plaintiffs have claimed that prolonged use of … Read more